Feedback
Pregabalin, Urine
2012229
Ordering Recommendation

Useful for general testing in contexts of compliance and/or abuse. Preferred test to follow-up presumptive results.

Mnemonic
PREGABA U
Methodology
Quantitative Liquid Chromatography/Tandem Mass Spectrometry
Performed
Tue, Sat
Reported
1-6 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Random urine. 
Specimen Preparation
Transfer 1 mL urine to an ARUP Standard Transport Tube. (Min: 0.6 mL) 
Storage/Transport Temperature
Refrigerated. 
Unacceptable Conditions
 
Remarks
 
Stability
Ambient: 1 month; Refrigerated: 1 month; Frozen: 1 month 
Reference Interval
By report
Interpretive Data
Positive cutoff: 0.5 µg/mL

For medical purposes only; not valid for forensic use.

The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration value must be greater than or equal to the cutoff to be reported as a quantitative result. Interpretive questions should be directed to the laboratory.

Compliance Statement B: This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Note
CPT Code(s)
80366 (Alt code: G0480)
Components
Component Test Code*Component Chart NameLOINC
2012230Pregabalin, Urine64125-8
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases